Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

There was an uneven distribution of the assigned maternal vitamin D supplementation group at enrollment; however, other baseline characteristics were similar between the BONUSKids+ participants and the BONUSKids cohort (Supplementary Table 1).Characteristics of children in Dhaka, Bangladesh for whom skeletal muscle mass was estimated using the D3-creatine dilution method.Participant characteristicsTotalBoysGirlsn = 100n = 52n = 48Age (months)a49.0 (0.4)49.0 (0.4)49.1 (0.4)Height (cm)a98.5 (4.3)99.7 (4.8)97.2 (3.3)Weight (kg)a14.5 (2.5)15.2 (2.8)13.8 (1.7)Height-for-age z-scorea−1.2 (1.0)−1.0 (1.1)−1.4 (0.8)BMI-for-age z-scorea−0.4 (1.1)−0.2 (1.2)−0.6 (0.9)D3Cr SMM (kg)a,b4.5 (0.9)4.6 (1.0)4.4 (0.8)D3Cr SMM/total body weight (%)a,b31.2 (4.9)30.2 (4.8)32.3 (4.8)ALM (kg)a,c3.2 (0.6)3.5 (0.7)3.0 (0.4)ALM/total body weight (%)a,c22.4 (1.9)23.0 (1.8)21.8 (1.8)Appendicular lean mass/height2 (kg/m2)a,c3.3 (0.4)3.5 (0.5)3.2 (0.3)TBLH fat mass (kg)a,c4.1 (1.4)4.1 (1.7)4.1 (1.0)TBLH lean mass (kg)a,c8.4 (1.3)9.0 (1.4)7.8 (0.9)TBLH lean mass/height2 (kg/m2)a,c8.6 (0.8)9.0 (0.8)8.3 (0.6)Upper extremities lean mass (kg)a,c0.7 (0.2)0.8 (0.2)0.6 (0.1)Lower extremities lean mass (kg)a,c2.5 (0.5)2.7 (0.6)2.3 (0.3)Maximum hand-grip strength (kg)a,d4.6 (1.3)4.7 (1.3)4.5 (1.3)Average hand-grip strength (kg)a,e3.6 (1.1)3.8 (1.1)3.5 (1.0)Average protein intake (g/day)a,f37.2 (14.6)39.0 (15.3)35.1 (13.8)Average energy intake (kcal/day)a,f1201 (375)1260 (411)1138 (324)Average protein energy percentagea,f,g12.4 (3.1)12.5 (3.0)12.2 (3.1)C-reactive protein below LLOQh, n (%)91 (96)47 (96)44 (96)Household asset index quintile i,n (%) 1 (lowest)22 (22)11 (21)11 (23) 224 (24)15 (29)9 (19) 321 (21)8 (15)13 (27) 421 (21)10 (19)11 (23) 5 (highest)12 (12)8 (15)4 (8) Maternal height (cm)a,j150.9 (5.4)151.5 (4.9)150.3 (5.8)Maternal BMI categoryk, n (%) Normal or underweight (<25 kg/m2)42 (43)22 (43)20 (42) Overweight (25: <30 kg/m2)37 (37)20 (39)17 (35) Obese (≥30 kg/m2)20 (20)9 (18)11 (23)Maternal level of educationj, n (%) Secondary incomplete or less80 (80)38 (73)42 (88) Secondary complete or higher20 (20)14 (27)6 (12)Maternal prenatal:postnatal vitamin D supplementation dose (IU/week), n (%) 0:024 (24)7 (13)17 (35) 2400:021 (21)13 (25)8 (17) 16,800:025 (25)14 (27)11 (23) 28,000:016 (16)6 (12)10 (21) 28,000:28,00014 (14)12 (23)2 (4)ALM appendicular lean mass measured by dual energy X-ray absorptiometry, D3Cr SMM skeletal muscle mass measured by D3-creatine dilution method, TBLH total-body-less-head.aPresented as mean (SD) (all such values).bn = 91, 5 children consumed incomplete D3Cr dose, 2 children provided a non-fasting urine sample, 2 children had implausible SMM (SMM > 50% of body weight).cn = 96; 2 children did not participate in the dual-energy x-ray absorptiometry scan, 2 scans were deemed unusable due to excess motion.dMaximum hand-grip strength is the maximum value of all completed attempts.eAverage hand-grip strength is the arithmetic mean of all attempts from both hands.fn = 99; dietary intake values for 1 child were considered implausible due to under-reporting (<500 kcal/d).gAverage protein energy percentage was calculated as the energy equivalent of the average daily protein intake in kcal (1 g protein = 4 kcal) divided by the average daily energy intake in kcal, multiplied by 100.hLLOQ (lower limit of quantification) for C-reactive protein was 1.6 mg/L, n = 95.iDetermined at mother’s enrollment in the Maternal Vitamin D for Infant Growth (MDIG) trial by claimed ownership of specific household items and computed using principal component analysis.jMaternal height and level of education collected at the MDIG trial enrollment visit were substituted for 2 participants whose mothers did not attend the BONUSKids+ study visit.kn = 99; weight was not measured for 11 mothers, BMI from 12 months post-partum was substituted where available.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Double-blind reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Briefly, MDIG was a double-blind, dose-ranging trial of maternal prenatal and postpartum vitamin D3 supplementation in Dhaka, Bangladesh (n = 1300), for which the primary outcome was infant linear growth at 12 months of age.

Source: Methods.

Since the accuracy of the D3Cr dilution method is dependent upon complete absorption of the tracer dose (D3Cr) for transport to skeletal muscle, the first 10 participants were simultaneously enrolled in a 3-day pilot study to determine: (i) whether any D3Cr was excreted into urine following ingestion (defined herein as “spillage”), and; (ii) whether a steady-state ratio of D3-labeled creatinine to total creatinine (enrichment) was reached.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Estimation of skeletal muscle mass in 4-year-old children using the D3-creatine dilution method

Study design awaiting verification · Pediatric Research · 2023

Original publication title

Estimation of skeletal muscle mass in 4-year-old children using the D3-creatine dilution method

Aysha Sidiqi; Farzana Fariha; Shaila S. Shanta; Alison Dasiewicz; Abdullah Al. Mahmud; Daniel R. Moore; Mahalakshmi Shankaran; Marc K. Hellerstein; William J. Evans; Alison D. Gernand; M. Munirul Islam; Steven A. Abrams; Jennifer Harrington; Edna Nyangau; Daniel E. Roth; Karen M. O’Callaghan

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The D3Cr dilution method was feasible in a community setting. However, high within-child variability in SMM estimates suggests the need for further optimization of this approach.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Given limited experience in applying the creatine-(methyl-D3) (D3Cr) dilution method to measure skeletal muscle mass (SMM) in young children, the feasibility of deployment in a fielding setting and performance of the method was assessed in a cohort of 4-year-old children in Dhaka, Bangladesh.

Source: Background

Abstract: What methods does the paper describe?

Following D3Cr oral dose (10 mg) administration, single fasting urine samples were collected at 2 to 4 days (n = 100). Twenty-four-hour post-dose collections and serial spot urine samples on days 2, 3 and 4 were obtained in a subset of participants (n = 10). Urinary creatine, creatinine, D3Cr and D3-creatinine enrichment were analyzed by liquid chromatography: tandem mass spectrometry. Appendicular lean mass (ALM) was measured by dual-energy x-ray absorptiometry and grip strength was measured by a hand-held dynamometer.

Source: Methods

Abstract: Impact

  • The D3-creatine (D3Cr) stable isotope dilution method was considered a feasible method for the estimation of skeletal muscle mass (SMM) in young children in a community setting and was well accepted among participants.

  • SMM was weakly associated with both dual-energy x-ray absorptiometry-derived values of appendicular lean mass and grip strength.

  • High within-child variability in estimated values of SMM suggests that further optimization of the D3Cr stable isotope dilution method is required prior to implementation in community research settings.

Source: Impact

Abstract: Results

SMM was measured successfully in 91% of participants, and there were no adverse events. Mean ± SD SMM was greater than ALM (4.5 ± 0.4 and 3.2 ± 0.6 kg, respectively). Precision of SMM was low (intraclass correlation = 0.20; 95% CI: 0.02, 0.75; n = 10). Grip strength was not associated with SMM in multivariable analysis (0.004 kg per 100 g of SMM; 95% CI: −0.031, 0.038; n = 91).

Source: Results

Abstract: Conclusions

The D3Cr dilution method was feasible in a community setting. However, high within-child variability in SMM estimates suggests the need for further optimization of this approach.

Source: Conclusions
Authors’ abstract

Background

Given limited experience in applying the creatine-(methyl-D3) (D3Cr) dilution method to measure skeletal muscle mass (SMM) in young children, the feasibility of deployment in a fielding setting and performance of the method was assessed in a cohort of 4-year-old children in Dhaka, Bangladesh.

Methods

Following D3Cr oral dose (10 mg) administration, single fasting urine samples were collected at 2 to 4 days (n = 100). Twenty-four-hour post-dose collections and serial spot urine samples on days 2, 3 and 4 were obtained in a subset of participants (n = 10). Urinary creatine, creatinine, D3Cr and D3-creatinine enrichment were analyzed by liquid chromatography: tandem mass spectrometry. Appendicular lean mass (ALM) was measured by dual-energy x-ray absorptiometry and grip strength was measured by a hand-held dynamometer.

Results

SMM was measured successfully in 91% of participants, and there were no adverse events. Mean ± SD SMM was greater than ALM (4.5 ± 0.4 and 3.2 ± 0.6 kg, respectively). Precision of SMM was low (intraclass correlation = 0.20; 95% CI: 0.02, 0.75; n = 10). Grip strength was not associated with SMM in multivariable analysis (0.004 kg per 100 g of SMM; 95% CI: −0.031, 0.038; n = 91).

Conclusions

The D3Cr dilution method was feasible in a community setting. However, high within-child variability in SMM estimates suggests the need for further optimization of this approach.

Impact

  • The D3-creatine (D3Cr) stable isotope dilution method was considered a feasible method for the estimation of skeletal muscle mass (SMM) in young children in a community setting and was well accepted among participants.

  • SMM was weakly associated with both dual-energy x-ray absorptiometry-derived values of appendicular lean mass and grip strength.

  • High within-child variability in estimated values of SMM suggests that further optimization of the D3Cr stable isotope dilution method is required prior to implementation in community research settings.

Publication and source details

Original title: Estimation of skeletal muscle mass in 4-year-old children using the D3-creatine dilution method

Aysha Sidiqi; Farzana Fariha; Shaila S. Shanta; Alison Dasiewicz; Abdullah Al. Mahmud; Daniel R. Moore; Mahalakshmi Shankaran; Marc K. Hellerstein; William J. Evans; Alison D. Gernand; M. Munirul Islam; Steven A. Abrams; Jennifer Harrington; Edna Nyangau; Daniel E. Roth; Karen M. O’Callaghan

Pediatric Research · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T19:44:05.504013+00:00

DOI: 10.1038/s41390-023-02587-1 · PMC10444613